Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT07924605
Overview
The goal of this clinical trial is to see if a drug called 18F-DCFPyL can help find prostate cancer or prostate cancer that has spread to other parts of the body. The main question it aims to answer is: * Can 18F-DCFPyL predict response to therapy; and, * Does 18F-DCFPyL improve detection of early signs of cancer. Participants will undergo PET/MRI scans.
Study contact
Abigail Wiedmer
Rad Study
Changhee Lee, MD Principal investigator
Drug / Compound
Eligibility
Exclusion criteria not yet provided.
Help us improve your experience